[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A ASPryadko, Mukhortova YR, Chernozem RV, Pariy I, Alipkina SI, Zharkova II, Dudun AA, Zhuikov VA, Moisenovich AM, Bonartseva GA, et al. Electrospun Magnetic Composite Poly-3-hydroxybutyrate/Magnetite Scaffolds for Biomedical Applications: Composition, Structure, Magnetic Properties, and Biological Performance. ACS Appl Bio Mater. 2022.
A Y Alqudah M, Agarwal S, Al-Keilani MS, Sibenaller ZA, Ryken TC, Assem M. NOTCH3 Is a Prognostic Factor That Promotes Glioma Cell Proliferation, Migration and Invasion via Activation of CCND1 and EGFR. PLoS One. 2013;8(10):e77299.
A Y Hamad I, Fei Y, Kalea AZ, Yin D, Smith AJP, Palmen J, Humphries SE, Talmud PJ, Walker AP. Demonstration of the Presence of the "Deleted" MIR122 Gene in HepG2 Cells. PLoS One. 2015;10(3):e0122471.
Aali E, Madjd Z, Tekiyehmaroof N, Sharifi AMohammad. Control of Hyperglycemia Using Differentiated and Undifferentiated Mesenchymal Stem Cells in Rats with Type 1 Diabetes. Cells Tissues Organs. 2020:1-13.
Aalikhani M, Alikhani M, Shamsabadi F, Oladnabi M, Bazi Z. In silico drug repurposing for the treatment of heart diseases using gene expression data and molecular docking techniques. Biochem Biophys Res Commun. 2021;572:138-144.
Aamar E, Laron EAvigad, Asaad W, Harshuk-Shabso S, Enshell-Seijffers D. Hair-follicle mesenchymal stem-cell activity during homeostasis and wound healing. J Invest Dermatol. 2021.
Aanei CMariana, Catafal LCampos. Evaluation of bone marrow microenvironment could change how myelodysplastic syndromes are diagnosed and treated. Cytometry A. 2018.
Aaronson Y, Livyatan I, Gokhman D, Meshorer E. Systematic identification of gene family regulators in mouse and human embryonic stem cells. Nucleic Acids Res. 2016.
Aarseth BL, Granerød CS, Galeckas A, Azarov A, Nguyen DPhuong, Prytz Ø, Vines L. Formation and functionalization of Ge-nanoparticles in ZnO. Nanotechnology. 2021.
Aarts CEM, Karampini E, Wüst T, Webbers S, Varga E, Geissler J, Voorberg J, von Lindern M, Bierings R, van den Akker E, et al. Generation and characterization of a control and patient-derived human iPSC line containing the Hermansky Pudlak type 2 (HPS2) associated heterozygous compound mutation in AP3B1. Stem Cell Res. 2021;54:102444.
Aarts CEM, Varga E, Webbers S, Geissler J, von Lindern M, Kuijpers TW, van den Akker E. Generation and characterization of a human iPSC line SANi008-A from a Chédiak-Higashi Syndrome patient. Stem Cell Res. 2021;55:102442.
Aarts CEM, Varga E, Webbers S, Geissler J, von Lindern M, Kuijpers TW, van den Akker E. Generation and characterization of a human iPSC line SANi007-A from a patient with a heterozygous dominant mutation in ELANE. Stem Cell Res. 2021;55:102440.
Aarts CEM, Varga E, Webbers S, Geissler J, von Lindern M, Kuijpers TW, van den Akker E. Generation and characterization of a human iPSC line SANi006-A from a Gray Platelet Syndrome patient. Stem Cell Res. 2021;55:102443.
Aarvold A, Smith JO, Tayton ER, Edwards CJ, Fowler DJ, Gent ED, Oreffo ROC. The role of osteoblast cells in the pathogenesis of unicameral bone cysts. J Child Orthop. 2012;6(4):339-46.
Aasen DM, M Vergara N. New Drug Discovery Paradigms for Retinal Diseases: A Focus on Retinal Organoids. J Ocul Pharmacol Ther. 2019.
Aathira R, Jain V. Advances in management of type 1 diabetes mellitus. World J Diabetes. 2014;5(5):689-96.
Ababneh NA, Al-Kurdi B, Ali D, Abuarqoub D, Barham R, Ryalat AT, Awidi A. Establishment of (JUCTCi007-A) iPSC line from a patient with congenital myasthenic syndrome (CMS) carrying a homozygous mutation p.Arg331Trp (c.991C > T) in the CHRNE gene. Stem Cell Res. 2020;47:101906.
Ababneh NA, Ali D, Barham R, Al-Kurdi B, Sharar N, Hadidi SAl, Qanno' O, Ryalat AT, Salah B, Awidi A. Establishment of a human induced pluripotent stem cell line, JUCTCi012-A, from multiple symmetric lipomatosis (MSL) patient carrying a homozygous Arg707Trp (c.2119C > T) mutation in the MFN2 gene. Stem Cell Res. 2020;48:101967.
Ababneh NA, Al-Kurdi B, Barham R, Ali D, Sharar N, Abuarqoub D, Jafar H, Salah B, Awidi A. Derivation of three human induced pluripotent stem cell lines (JUCTCi014-A, JUCTCi015-A, JUCTCi016-A) from mesenchymal stem cells (MSCs) derived from bone marrow, adipose tissue and Wharton's jelly samples. Stem Cell Res. 2020;49:102000.
Ababneh NA, Barham R, Al-Kurdi B, Ali D, Sharar N, Hadidi SAl, Alatoom RM, Zalloum S, Gharandouq MH, Makahleh L, et al. Generation of an induced pluripotent stem cell (iPSC) line (JUCTCi017-A) from a patient with limb-girdle muscular dystrophy (LGMD) due to a homozygous p.Lue287Ser fs14* mutation in the SGCB gene. Stem Cell Res. 2021;54:102358.
Ababneh NA, Barham R, Al-Kurdi B, Ali D, Hadidi SAl, Ismail MA, Muamar ASH, Abdulelah AA, Madadha A, Sallam M, et al. Generation of a human induced pluripotent stem cell (iPSC) line (JUCTCi019-A) from a patient with Charcot-Marie-Tooth disease type 2A2 (CMT2A2) due to a heterozygous missense substitution c.2119C > T (p.Arg707Trp) in MFN2 gene. Stem Cell Res. 2022;62:102786.
Ababneh HS, Abramson JS, P Johnson C, Patel CG. Assessing the Role of Radiotherapy in Patients with Refractory or Relapsed High-Grade B-Cell Lymphomas Treated with CAR T-Cell Therapy. Radiother Oncol. 2022.
Ababou M, Mehtat EMehdi, Jennane S, Elmaaroufi H, Mikdame M, Doghmi K. Splenic marginal zone lymphoma associated with hepatitis B virus infection, remission after viral treatment, and splenectomy: A case report and review of the literature. Hematol Oncol Stem Cell Ther. 2019.
Ababzadeh S, Farzin A, Goodarzi A, Karimi R, Farahani MSagharjogh, Farsani MEslami, Gharibzad K, Zahiri M, Ai J. High porous electrospun poly(ε-caprolactone)/gelatin/MgO scaffolds preseeded with endometrial stem cells promote tissue regeneration in full-thickness skin wounds: An in vivo study. J Biomed Mater Res B Appl Biomater. 2020.